Journal
NUCLEAR MEDICINE AND BIOLOGY
Volume 35, Issue 8, Pages 869-874Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2008.09.002
Keywords
[(18)F]FDDNP; Amyloid; Metabolism; BBB transport; PET
Funding
- DiMI [LSHB-CT-2005-512146]
Ask authors/readers for more resources
[(18)F]FDDNP is a positron emission tomography (PET) tracer for determining amyloid plaques and neurofibrillary tangles in the brain in vivo. in order to quantify binding of this tracer properly, a metabolite-corrected plasma input function is required. The purpose of the present Study was to develop a sensitive method for measuring [(18)F]FDDNP and its radiolabelled metabolites in plasma. The second aim was to assess whether these radiolabelled metabolites enter the brain. In humans, there was extensive metabolism of [(18)F]FDDNP. After 10 min, more than 90% of plasma radioactivity was identified as polar (18)F-labelled fragments, probably formed from N-dealkylation of [(18)F]FDDNP. These labelled metabolites were reproduced in vitro using human hepatocytes. PET studies in rats showed that these polar metabolites can penetrate the blood-brain barrier and result in uniform brain uptake. (c) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available